Matthew R. Kwietniak - 11 Apr 2024 Form 4 Insider Report for Avid Bioservices, Inc.

Role
Chief Commercial Officer
Signature
/s/ Stephen Hedberg, by Power of Attorney for Matthew R. Kwietniak
Issuer symbol
N/A
Transactions as of
11 Apr 2024
Net transactions value
$0
Form type
4
Filing time
12 Apr 2024, 19:35:25 UTC
Previous filing
11 Apr 2024
Next filing
02 May 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CDMO Common Stock, $0.001 par value Options Exercise +669 +3% 23,030 11 Apr 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CDMO Restricted Stock Units Options Exercise $0 -669 -2.1% $0.000000 31,896 11 Apr 2024 Common Stock 669 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit ("RSU") represents the contingent right to receive, upon vesting, one share of the Issuer's Common Stock.
F2 RSUs granted to the reporting person on October 11, 2021, is subject to a four (4) vesting schedule. 25% vested on the first anniversary of the date of grant, and the remaining balance vest in twelve (12) equal quarterly installments beginning January 11, 2023 and each quarter thereafter until fully-vested, subject to the reporting person's continuous service to the Issuer on such vesting dates.